Hua Wang

发表

Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring.

Xiao-li Feng, Jiade J Lu, Shulian Wang, 2008, Blood.

Variable Clinical Presentations of Nasal and Waldeyer Ring Natural Killer/T-Cell Lymphoma

Jiade J Lu, Shulian Wang, J. Jin, 2009, Clinical Cancer Research.

Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study

Chen Hu, Gang Wu, Jun Zhu, 2020, Leukemia.

First-line non-anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG.

Chen Hu, Gang Wu, Jun Zhu, 2020, Blood advances.

Risk‐based, response‐adapted therapy for early‐stage extranodal nasal‐type NK/T‐cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study

Chen Hu, Gang Wu, Jun Zhu, 2020, American journal of hematology.

Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK/T-cell lymphoma patients receiving primary radiotherapy.

Shulian Wang, J. Jin, Ye-Xiong Li, 2012, Blood.

Mild toxicity and favorable prognosis of high-dose and extended involved-field intensity-modulated radiotherapy for patients with early-stage nasal NK/T-cell lymphoma.

J. Dai, Shulian Wang, J. Jin, 2012, International journal of radiation oncology, biology, physics.

Characteristics and prognosis of distant metastasis after primary treatment for early‐stage extranodal nasal‐type natural killer/T‐cell lymphoma from the China Lymphoma Collaborative Group database

Jun Zhu, Yu-jing Zhang, S. Qi, 2022, EJHaem.

Radiotherapy alone with curative intent in patients with stage I extranodal nasal-type NK/T-cell lymphoma.

Shulian Wang, J. Jin, Qingfeng Liu, 2012, International journal of radiation oncology, biology, physics.

Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making

R. Tsang, Chen Hu, Gang Wu, 2020, Leukemia.

Diffuse large B‐cell lymphoma

Shulian Wang, J. Jin, S. Qi, 2009, Cancer.

Immunophenotypic characteristics and clinical relevance of CD56+ and CD56− extranodal nasal-type natural killer/T-cell lymphoma

Xiao-li Feng, Shulian Wang, J. Jin, 2011, Leukemia & lymphoma.

Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents.

Shulian Wang, J. Jin, H. Fang, 2009, Blood.

Clinical characteristics, treatment, and survival of 30 patients with gastrointestinal natural killer/T-cell lymphoma.

Jun Zhu, Yu-jing Zhang, S. Qi, 2023, Cancer reports.

Treatment, Survival, and Prognosis of Advanced-Stage Natural Killer/T-Cell Lymphoma: An Analysis From the China Lymphoma Collaborative Group

Jun Zhu, Yu-jing Zhang, N. Lin, 2021, Frontiers in Oncology.

Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study

Jun Zhu, Shulian Wang, Yu-jing Zhang, 2023, Annals of Hematology.

Radiotherapy alone with curative intent in patients with stage I extranodal nasal-type NK/T-cell lymphoma.

Shulian Wang, J. Jin, Qingfeng Liu, 2012, International journal of radiation oncology, biology, physics.

Optimizing the combination of chemotherapeutic drugs along with radiotherapy for extranodal NK/T-cell lymphoma

Yu-jing Zhang, Hua Wang, Ying Wang, 2024, Therapeutic advances in medical oncology.